Important Disclosure Information. Read Before Proceeding.
Companies
Neuralink
Neuralink
San Francisco, CA
Founded 2016
Healthcare
Neuralink is a developer of brain-machine interfaces, building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world.
neuralink.com|X (Twitter)|LinkedIn|Crunchbase
Last Round Valuation
$9.65B
Last Round Share Price
$ XX.XY
Total Funding
$1.3B
Last Round
Series E
Neuralink
$199.25
Fund Marks
1M
3M
YTD
1Y
2Y
MAX
Powered by Caplight

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here
Information contained herein is based on estimates and is subject to update.

Mutual Funds

Nothing here
Let us know if we are missing anything

News

Neuralink Secures FDA Approval for Human Trials thumbnail image
04/27/2026
Neuralink Secures FDA Approval for Human Trials
Neuralink's FDA approval for human trials positions the company at the forefront of neurotechnology, potentially unlocking significant market opportunities and attracting substantial investment in a sector poised for rapid growth and innovation.
The Times of IndiaFast Company Middle EastThe Verge
Neuralink Secures Investment from Oman Investment Authority thumbnail image
04/25/2026
Neuralink Secures Investment from Oman Investment Authority
Neuralink's investment from the Oman Investment Authority signals increasing global interest in neurotechnology, potentially accelerating advancements in brain-computer interfaces and positioning the company for significant market leadership as it seeks to scale operations.
TradingViewNewsBytesMoneycontrol.com
BrainCo Files for Hong Kong IPO Amid Neuralink Competition thumbnail image
04/22/2026
BrainCo Files for Hong Kong IPO Amid Neuralink Competition
BrainCo's Hong Kong IPO filing signals a strategic move to capitalize on the burgeoning brain-computer interface market, intensifying competition with Neuralink and potentially attracting significant investment amid rising valuations in the tech sector.
Forbes

Research

Neuralink One-Pager
Synchron One-Pager
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Is trading on Augment safe and legitimate?
How do Augment fees work?
How can I get notified when there are new interested buyers of my shares?
Which companies are listed on Augment’s marketplace?
How do I know if an order is created by a broker or a direct buyer or user?
What is the typical process of selling shares?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
What is required to join Augment?
Are orders posted anonymously?
Augment
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.